Newsletters

Psychiatry Advisor

• Who Diagnoses Autism? Expert Views From Neurology, Psychiatry, and Psychology April 26, 2024
  In a discussion panel, a pediatric neurologist, a psychiatrist, and a clinical neuropsychologist share their insights on screening for and diagnosing autism. The post Who Diagnoses Autism? Expert Views From Neurology, Psychiatry, and Psychology appeared first on Psychiatry Advisor.
  Addie
• Psychiatric Disorders Do Not Decrease COVID-19 Vaccine Effectiveness April 26, 2024
  Researchers conducted a retrospective cohort analysis to evaluate the effectiveness of COVID-19 vaccination among US adults with common psychiatric disorders. The post Psychiatric Disorders Do Not Decrease COVID-19 Vaccine Effectiveness appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Off-Label Use of ADHD Medications for Patients With Bipolar Disorder April 26, 2024
  Investigators evaluated the utility of off-label use of ADHD medications for treating ADHD symptoms and cognitive function among patients with bipolar disorder. The post Off-Label Use of ADHD Medications for Patients With Bipolar Disorder appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Rapid Transitions Seen From Neutral to Negative Emotional States in PTSD April 26, 2024
  Individuals with posttraumatic stress disorder (PTSD) undergo rapid transitions between neutral and negative emotional states. The post Rapid Transitions Seen From Neutral to Negative Emotional States in PTSD appeared first on Psychiatry Advisor.
  Haymarket Media
• Green Space May Benefit Mental Health in Early Childhood April 26, 2024
  Green space is associated with fewer internalizing symptoms in early childhood, according to a study published online. The post Green Space May Benefit Mental Health in Early Childhood appeared first on Psychiatry Advisor.
  Haymarket Media
• Low-sodium Oxybate Improves Idiopathic Hypersomnia Symptoms, Even Sleep Inertia April 26, 2024
  In an analysis of a phase 3 trial, researchers assessed the effect of low-sodium oxybate on sleep inertia in patients with idiopathic hypersomnia. The post Low-sodium Oxybate Improves Idiopathic Hypersomnia Symptoms, Even Sleep Inertia appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Anti-Inflammatory Use May Reduce PD Risk in Patients With Autoimmune Diseases April 26, 2024
  Researchers examined the relationship between exposure to anti-inflammatory therapy and the incidence of Parkinson disease in patients with autoimmune conditions. The post Anti-Inflammatory Use May Reduce PD Risk in Patients With Autoimmune Diseases appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Lemborexant for Insomnia: Over 50% of Older Adults Respond Well After 1 Month April 26, 2024
  Researchers explored response and remission rates in older adults with insomnia disorder and objective short sleep receiving lemborexant treatment. The post Lemborexant for Insomnia: Over 50% of Older Adults Respond Well After 1 Month appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Transition to Low-Sodium Oxybate is Easy, Preferred in Patients With Narcolepsy April 26, 2024
  Researchers explored the safety, effectiveness, tolerability, and treatment optimization in patients with narcolepsy who transition from sodium oxybate to low-sodium oxybate. The post Transition to Low-Sodium Oxybate is Easy, Preferred in Patients With Narcolepsy appeared first on Psychiatry Advisor.
  Meahjabeen Hoque
• Autism Heritability Differs Between Men and Women April 25, 2024
  Researchers conducted a population-based study to determine sex differences in autism heritability within families, using Swedish national register data. The post Autism Heritability Differs Between Men and Women appeared first on Psychiatry Advisor.
  Meahjabeen Hoque